UT Health, Ohio company reach license agreement to develop chlamydia vaccine
<p>Vaccines for this infection have been challenging to produce UT Health has granted an exclusive global license allowing an Ohio biopharmaceutical company to develop university research discoveries into a novel oral vaccine for chlamydia. According to the U.S. Centers for Disease Control and Prevention (CDC), chlamydia is the bacterial sexually transmitted infection most frequently reported […]</p>